Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships.

Author: CornagliaG, FirsovA A, LubenkoI Y, PortnoyY A, VostrovS N, ZinnerS H

Paper Details 
Original Abstract of the Article :
To compare the antimicrobial effects of gemifloxacin and trovafloxacin on Staphylococcus aureus, their pharmacodynamics were studied in an in vitro dynamic model. A series of pharmacokinetic profiles of gemifloxacin and trovafloxacin with half-lives of 7.4 and 9.2 h, respectively, were simulated in ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0732-8893(01)00264-4

データ提供:米国国立医学図書館(NLM)

Gemifloxacin and Trovafloxacin: A Comparative Analysis of Anti-Staphylococcal Effects

Staphylococcus aureus is a common bacterium that can cause a range of infections. This study compares the antimicrobial effects of two fluoroquinolones, gemifloxacin and trovafloxacin, against S. aureus, focusing on their pharmacokinetic and pharmacodynamic properties.

The researchers used an in vitro dynamic model to simulate the pharmacokinetic profiles of these drugs. They found that both gemifloxacin and trovafloxacin exhibited linear, species- and strain-independent relationships between the intensity of antimicrobial effect and the AUC/MIC ratio. However, at higher AUC/MIC ratios, trovafloxacin demonstrated a greater antimicrobial effect than gemifloxacin.

A Race Across the Desert of Antimicrobial Activity

This study is like a camel caravan racing across the desert, comparing the effectiveness of different antimicrobial agents against a common foe.

A Comparative Analysis of Anti-Staphylococcal Agents

This research is like a desert oasis offering a variety of remedies for combating a common infection – it provides a detailed comparison of the antimicrobial properties of gemifloxacin and trovafloxacin.

Dr. Camel's Conclusion

This study is like a camel caravan exploring two different routes through the desert – it provides a detailed comparison of the antimicrobial effectiveness of gemifloxacin and trovafloxacin, revealing the nuances of their respective strengths and weaknesses.

Date :
  1. Date Completed 2001-12-13
  2. Date Revised 2019-09-06
Further Info :

Pubmed ID

11576789

DOI: Digital Object Identifier

10.1016/s0732-8893(01)00264-4

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.